Customize your JAMA Network experience by selecting one or more topics from the list below.
Luong PM, Tsui E, Batra N, Chapman CB, Zegans ME. Vision Loss Associated With the Opioid Epidemic. JAMA Ophthalmol. 2017;135(12):1449–1451. doi:10.1001/jamaophthalmol.2017.4868
The United States experienced a tripling in the number of opioid overdose deaths from 2000 to 2014. In particular, the Northeast region has the highest age-adjusted rate of deaths associated with drug use, at 16.1 per 100 000 persons.1 In New Hampshire, the rate is even higher, at 26.2 per 100 000 persons.1
A devastating sequela of injection drug use (IDU) is endogenous endophthalmitis (EE).2 Injection drug use can lead to transient microbial bloodstream infection from use of a nonsterile injection apparatus, which can seed ocular infection.3 The prognosis of EE is poor, with nearly 50% of affected eyes having no light perception despite treatment.2 We investigated clinical characteristics of IDU vs non-IDU EE at Dartmouth-Hitchcock Medical Center (DHMC), Lebanon, New Hampshire, during the opioid epidemic.
Create a personal account or sign in to: